At present, patients with ocular trauma can be treated with medication, laser therapy and surgery to prevent proliferative lesions, but the therapeutic effect varies among individuals. Currently, the more effective drug treatment is to inject anti-vascular endothelial growth factor (VEGF), such as abciximab, compazine, ranibizumab, etc., into the vitreous cavity, which can effectively inhibit neovascularization, thus preventing proliferative lesions. Laser surgery is a commonly used treatment for vitreoretinal proliferative diseases, which can effectively inhibit the growth of neovascularization, thus preventing serious complications such as fundus hemorrhage and retinal detachment that may be caused by rupture of the neovascularization, but it usually requires multiple laser surgeries to have an effect. If patients experience serious complications such as retinal detachment, they need to undergo vitrectomy in time to close all retinal tears and reduce the pull of the proliferating membrane on the retina, thus improving their symptoms. It is recommended that patients with ocular trauma seek prompt medical attention to evaluate their condition and follow medical advice.